Opus Genetics, Inc. (IRD) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Join SI Premium – FREE
Opus Genetics, Inc. (NASDAQ: IRD) reported Q1 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $4.37 million versus the consensus estimate of $2 million.
For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- JPMorgan Upgrades Grupo Aval (AVAL) to Neutral
- Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
